The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cytokines performance during nivolumab treatment: A subgroup analysis of NIVACTOR study.
 
Nerina Denaro
Speakers' Bureau - Bristol-Myers Squibb; Merck
 
Matteo Paccagnella
Employment - Bruschettini (I)
 
Danilo Galizia
Honoraria - Istituto Gentili
Travel, Accommodations, Expenses - Pfizer
 
Antonella Falletta
No Relationships to Disclose
 
Andrea Abbona
No Relationships to Disclose
 
Loretta Gammaitoni
No Relationships to Disclose
 
Erika Fiorino
No Relationships to Disclose
 
Lorena De Zarlo
No Relationships to Disclose
 
Paolo Bossi
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Regeneron
Consulting or Advisory Role - Angelini Pharma; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Sanofi/Regeneron; Sun Pharma
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD Oncology (Inst); Regeneron (Inst); Roche (Inst)
 
Dario Sangiolo
Honoraria - Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Doxapharma; Eisai; GlaxoSmithKline; Incyte; Ipsen; Merck Serono; MSD; Nanobiotix; Novartis; Roche; SOBI
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck Serono; MSD
 
Massimo Aglietta
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck; Novartis
Research Funding - AstraZeneca (Inst); PharmaMar
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; MERCK; tesaro
 
Marco Carlo Merlano
Honoraria - Bristol Myers Squibb Foundation; Merck Serono; Merck Sharp & Dohme
Consulting or Advisory Role - Debiopharm Group